Clinical Trial Update: Refining Local-Regional Therapy for IBC [NA]

View source ↗

Summary

A Dana-Farber Cancer Institute–led clinical trial is refining local-regional therapy for inflammatory breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Inflammatory Breast Cancer | NA | Status: RECRUITING